ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008

Tobaccos Council Awards New Grants

April 3, 1981

Adriamycin Update Discussed At Seminar

January 10, 1975

In Brief: Sparano Named Vice Chair of ECOG-ACRIN

May 17, 2013

Duke Promised $11.5M For Eye, Lung Research.

March 8, 2002

Obituaries: Keith Amos, Trudy Small, and Kie Kian Ang

June 21, 2013